Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...

"HCM is a heart muscle disease associated with a significant symptom burden. This approval of a new drug, Myqorzo, represents a meaningful addition to the treatment options available for symptomatic ...

Chevy Chase revealed he was in a coma for eight days after experiencing heart failure, new CNN documentary "I'm Chevy Chase ...

Chevy Chase is opening up about a health scare that landed him in the hospital for five weeks.

Chevy Chase and his loved ones are opening up about the eight days he spent in a medically induced coma amid his near-fatal ...

His daughter, Caley Chase, said that he doesn’t recall any of the incidents because he “came back from the dead,” bringing up ...

The phrase “scared to death” isn’t just a metaphor. For people with Takotsubo cardiomyopathy - also known as broken heart ...

Heart failure in which left ventricular ejection fraction recovers into the normal range has many unknowns. Andrew Perry, MD, discusses key management strategies with Jane Wilcox, MD, of Northwestern ...

The diagnosis of a potentially lethal cardiovascular disease in a young athlete presents a complex dilemma regarding athlete safety, patient autonomy, team or institutional risk tolerance and medical ...

A diagnosis of stress-induced cardiomyopathy is also known as takotsubo cardiomyopathy and broken heart syndrome. It means the heart has been weakened by an acute period of emotional or physical ...

Peripartum cardiomyopathy is a form of acute and sometimes severe cardiac degeneration that leads to clinical heart failure during pregnancy or in the early postpartum period. The disorder is ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), today announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical ...